Bidirectional Mendelian Randomization and Colocalization Study of Memory B Cells and Major Depressive Disorder

Abstract

Objective

Emerging evidence implicates neuroinflammation in the pathogenesis of major depressive disorder (MDD), yet the role of memory B cells remains unclear. In this study, we conducted a bidirectional two-sample Mendelian randomization (MR) study and Bayesian colocalization analyses to investigate the causal relationships between memory B-cell traits and MDD risk.

Methods

MDD summary data were gathered from a meta-analysis of genome-wide association studies (GWASs), whereas memory B-cell genetic variations were sourced from GWASs on immune phenotypes. MR analysis utilized the inverse variance weighted (IVW), MR-Egger, and weighted median methods. Moreover, various sensitivity analyses, including Cochran’s Q test, MR Pleiotropy Residual Sum and Outlier (MR-PRESSO), MR-Egger intercept test and Leave-one-out (LOO) analysis, were performed to confirm MR result stability. Bayesian colocalization analyses were also conducted to identify genetic loci shared between memory B cells and MDD.

Results

Our results indicated that genetically predicted increased CD27 protein expression on memory B cells causally elevated MDD risk (ORs: 1.025–1.063, P_FDR < 0.05). Conversely, MDD did not causally affect memory B-cell traits. Additionally, the colocalization analysis revealed no shared genetic variants, suggesting distinct biological pathways.

Conclusions

These findings highlight CD27 as a potential novel biomarker and therapeutic target in MDD, warranting further clinical validation in the future.

Keywords

Major depressive disorder / Memory B cells / Mendelian randomization / Colocalization analysis / Neuroinflammation / CD27 / Immunopsychiatry / B cell activation

References

[1] Cui R. Editorial: a systematic review of depression. Curr Neuropharmacol., 2015, 13(4): 480

[2] McCarron RM, Shapiro B, Rawles J, et al. Depression. Ann Intern Med. 2021:ITC65–ITC80.

[3] Malhi GS, Mann JJ. Depression. Lancet., 2018, 392(101612299-2312

[4] Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature., 2008, 455(7215): 894-902

[5] Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation., 2021, 18(1): 258

[6] Troubat R, Barone P, Leman S, et al.. Neuroinflammation and depression: a review. Eur J Neurosci., 2021, 53(1151-171

[7] Wu A, Zhang J. Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis. J Neuroinflammation., 2023, 20(1): 283

[8] Setiawan E, Wilson AA, Mizrahi R, et al.. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry., 2015, 72(3268-275

[9] Torres-Platas SG, Cruceanu C, Chen GG, et al.. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun., 2014, 42: 50-59

[10] Steiner J, Bielau H, Brisch R, et al.. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res., 2008, 42(2): 151-157

[11] Nagy C, Suderman M, Yang J, et al.. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol Psychiatry., 2015, 20(3): 320-328

[12] Feinstein A, Magalhaes S, Richard JF, et al.. The link between multiple sclerosis and depression. Nat Rev Neurol., 2014, 10(9): 507-517

[13] Ownby RL, Crocco E, Acevedo A, et al.. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry., 2006, 63(5): 530-538

[14] McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry., 2003, 54(3): 363-375

[15] Wang H, He Y, Sun Z, et al.. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation., 2022, 19(1): 132

[16] Guo F, Fan J, Liu JM, et al.. Astrocytic ALKBH5 in stress response contributes to depressive-like behaviors in mice. Nat Commun., 2024, 15(14347

[17] Réus GZ, Manosso LM, Quevedo J, et al.. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities. Neurosci Biobehav Rev., 2023, 155 105425

[18] Ahmetspahic D, Schwarte K, Ambrée O, et al.. Altered B cell homeostasis in patients with major depressive disorder and normalization of CD5 surface expression on regulatory B cells in treatment responders. J Neuroimmune Pharmacol., 2018, 13(190-99

[19] Inoue T, Kurosaki T. Memory B cells. Nat Rev Immunol., 2024, 24(1): 5-17

[20] LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood., 2008, 112(5): 1570-1580

[21] Li R, Rezk A, Miyazaki Y, et al.. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med., 2015, 7(310): 310ra166

[22] Cognasse F, Hamzeh-Cognasse H, Lafarge S, et al.. Identification of two subpopulations of purified human blood B cells, CD27- CD23⁺ and CD27high CD80⁺, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6. Immunology., 2008, 125(3430-437

[23] Duddy M, Niino M, Adatia F, et al.. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol., 2007, 178(10): 6092-6099

[24] Ramesh A, Schubert RD, Greenfield AL, et al.. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc Natl Acad Sci U S A., 2020, 117(37): 22932-22943

[25] Zhang Y, Miao Y, Tan J, et al.. Identification of mitochondrial related signature associated with immune microenvironment in Alzheimer’s disease. J Transl Med., 2023, 21(1): 458

[26] Wang P, Luo M, Zhou W, et al.. Global characterization of peripheral B cells in Parkinson’s disease by single-cell RNA and BCR sequencing. Front Immunol., 2022, 13 814239

[27] Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ., 2018, 362 k601

[28] Howard DM, Adams MJ, Clarke TK, et al.. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci., 2019, 22(3343-352

[29] Orrù V, Steri M, Sidore C, et al.. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet., 2020, 52(10): 1036-1045

[30] Luo J, Xu Z, Noordam R, et al.. Depression and inflammatory bowel disease: a bidirectional two-sample mendelian randomization study. J Crohns Colitis., 2022, 16(4): 633-642

[31] Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–764.

[32] Yao C, Zhang Y, Lu P, et al.. Exploring the bidirectional relationship between pain and mental disorders: a comprehensive Mendelian randomization study. J Headache Pain., 2023, 24(1): 82

[33] Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol., 2013, 37(7658-665

[34] Qiu S, Cao P, Guo Y, et al.. Exploring the causality between hypothyroidism and non-alcoholic fatty liver: a mendelian randomization study. Front Cell Dev Biol., 2021, 9 643582

[35] Bowden J, Davey Smith G, Haycock PC, et al.. Consistent estimation in mendelian randomization with some invalid instruments using a weighted Median estimator. Genet Epidemiol., 2016, 40(4): 304-314

[36] Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol., 2015, 44(2): 512-525

[37] Burgess S, Davey Smith G, Davies NM, et al.. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res., 2019, 4: 186

[38] Verbanck M, Chen CY, Neale B, et al.. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet., 2018, 50(5): 693-698

[39] Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol., 2017, 32(5377-389

[40] Ou YN, Yang YX, Deng YT, et al.. Identification of novel drug targets for Alzheimer’s disease by integrating genetics and proteomes from brain and blood. Mol Psychiatry., 2021, 26(10): 6065-6073

[41] Lu T, Chen Y, Yoshiji S, et al.. Circulating metabolite abundances associated with risks of bipolar disorder, schizophrenia, and depression: a mendelian randomization study. Biol Psychiatry., 2024, 96(10): 782-791

[42] Sanz I, Wei C, Lee FE, et al.. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol., 2008, 20(1): 67-82

[43] Castellani G, Croese T, Peralta Ramos JM, et al.. Transforming the understanding of brain immunity. Science., 2023, 380(6640): eabo7649

[44] Crupi R, Cuzzocrea S. Neuroinflammation and immunity: a new pharmacological target in depression. CNS Neurol Disord Drug Targets., 2016, 15(4464-476

[45] Aranda CJ, Gonzalez-Kozlova E, Saunders SP, et al.. IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases. Allergy., 2023, 78(3): 752-766

[46] Yang M, Long D, Hu L, et al.. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther., 2021, 6(1): 341

[47] Agematsu K, Hokibara S, Nagumo H, et al.. CD27: a memory B-cell marker. Immunol Today., 2000, 21(5204-206

[48] Agematsu K, Nagumo H, Oguchi Y, et al.. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood., 1998, 91(1): 173-180

[49] Agematsu K, Kobata T, Yang FC, et al.. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol., 1995, 25(10): 2825-2829

[50] Avery DT, Ellyard JI, MacKay F, et al.. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J Immunol., 2005, 174(7): 4034-4042

[51] Nutt SL, Hodgkin PD, Tarlinton DM, et al.. The generation of antibody-secreting plasma cells. Nat Rev Immunol., 2015, 15(3): 160-171

[52] Hoyer BF, Radbruch A. Protective and pathogenic memory plasma cells. Immunol Lett., 2017, 189: 10-12

[53] Shimo Y, Cathomas F, Lin HY, et al.. Social stress induces autoimmune responses against the brain. Proc Natl Acad Sci U S A., 2023, 120(49 e2305778120

[54] Hukku A, Pividori M, Luca F, et al.. Probabilistic colocalization of genetic variants from complex and molecular traits: promise and limitations. Am J Hum Genet., 2021, 108(1): 25-35

[55] Zuber V, Grinberg NF, Gill D, et al.. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am J Hum Genet., 2022, 109(5): 767-782

[56] Yao PA, Sun HJ, Li XY. Identification of key genes in late-onset major depressive disorder through a co-expression network module. Front Genet., 2022, 13: 1048761

[57] Maes M, Zhou B, Rachayon M, et al.. T cell activation and lowered T regulatory cell numbers are key processes in severe major depressive disorder: Effects of recurrence of illness and adverse childhood experiences. J Affect Disord., 2024, 362: 62-74

[58] Rothmore J. Antidepressant-induced sexual dysfunction. Med J Aust., 2020, 212(7): 329-334

[59] Park LT, Zarate CAJr. Depression in the primary care setting. N Engl J Med., 2019, 380(6): 559-568

[60] US Preventive Services Task ForceBarry MJ, Nicholson WK, et al.. Screening for depression and suicide risk in adults: us preventive services task force recommendation statement. JAMA., 2023, 329(23): 2057-2067

[61] O’Connor EA, Perdue LA, Coppola EL, et al.. Depression and suicide risk screening: updated evidence report and systematic review for the US preventive services task force. JAMA., 2023, 329(23): 2068-2085

[62] Saleh A, Potter GG, McQuoid DR, et al.. Effects of early life stress on depression, cognitive performance and brain morphology. Psychol Med., 2017, 47(1): 171-181

[63] Assari S. Social determinants of depression: the intersections of race, gender, and socioeconomic status. Brain Sci., 2017, 7(12): 156

[64] Velázquez-Alva MC, Irigoyen-Camacho ME, Cabrer-Rosales MF, et al.. Prevalence of malnutrition and depression in older adults living in nursing homes in Mexico City. Nutrients., 2020, 12(82429

[65] Gutiérrez-Rojas L, Porras-Segovia A, Dunne H, et al.. Prevalence and correlates of major depressive disorder: a systematic review. Braz J Psychiatry., 2020, 42(6657-672

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to the Huazhong University of Science and Technology

Just Accepted

This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.